- Home
- PULM vs AMST Comparison
PULM vs AMST Comparison
Compare PULM & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PULM | AMST |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 6.1M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PULM | AMST |
|---|---|---|
| Price | $1.42 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.5K | ★ 74.4K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.18 | 38.83 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,910,000.00 | $364,777.00 |
| Revenue This Year | N/A | $19,089.81 |
| Revenue Next Year | $67.27 | $22.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5069.93 | 230.24 |
| 52 Week Low | $1.16 | $0.63 |
| 52 Week High | $4.98 | $3.90 |
Technical Indicators
Market Signals| Indicator | PULM | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 18.08 |
| Support Level | $1.21 | N/A |
| Resistance Level | $1.46 | $1.11 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 21.41 | 0.03 |
Price Performance
Historical ComparisonAbout PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About AMST Amesite Inc.
Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.